Bronchitis Treatment Market to Reach USUSD 4.7 Bn by 2026, High Prevalence of Air Pollution Drives Growth: Transparency Market Research
T
he global Bronchitis Treatment Market is set to grow at a 3.6pc , compounded annually over the period 2018 to 2026 owing to a number of factors that mark the landscape over the coming few years.
Increase in pollution and adoption of lifestyle choices detrimental to health such as smoking, lack of exercise, and poor diets are major factors leading to poor health in general and weak respiratory system in particular. As incidence of bronchitis increases worldwide, so would increase the demand for bronchitis treatment over the forecast period, states Transparency Market Research.
Key Findings of the Bronchitis Treatment Market Study
Chronic Bronchitis segment based on type to dominate the global bronchitis treatment market landscape over the forecast period
Increase in development and sale of over-the-counter therapeutics to drive retail pharmacies towards a higher market share
Increase in number of smokers, and people aged 60 and above to drive growth in market significantly
View Detailed Table of Contents at - https//www.transparencymarketresearch.com/report-toc/62775
Bronchitis Treatment Market Key Driving Factors
The global bronchitis treatment market is witnessing multiple factors driving and sustaining growth over the forecast period. As per Transparency Market Research, the market is riding the wave of ageing population worldwide, the numbers for which are pronounced in certain regions such as North America and Europe. The other factor that marks growth in demand for bronchitis treatment is increase in prevalence due to increasing pollution levels. It is important to note the following markers, which are paving way for projected market growth
Air pollution takes 9 million deaths globally and is a major cause of COPD and other respiratory system related diseases; developing regions of the world are particularly susceptible as economic growth is often driven by industrialization, and a lack of resources to adopt technologically advanced systems for mitigating pollution leads to high levels of harmful emissions
Globally, one in every six people would be aged 65 and above by the year 2050, leading to a large segment of population susceptible to breathing and lung related medical issues. This segment will be crucial in generating demand for bronchitis treatment over the assessment period
Explore 176 pages of top-notch research, incisive insights, and detailed country-level projections. Gain business intelligence on bronchitis treatment market by Type - Chronic Bronchitis, Acute Bronchitis; Drug Class - Antibiotics, Anti-inflammatory Drugs, Bronchodilator, Mucolytics; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Key Impediments for Global Bronchitis Treatment Market Players
As per an extensive research carried out by Transparency Market Research on bronchitis treatment, the market is on an upward growth trajectory from 2018 to 2026. However, patent expiry looming over the forecast period, would be a market restraint, keeping the market from reaching its real potential for growth. However, research and development undertaken in the field will pave way for higher growth in the future. Thus, players in the market would have a keen focus on improving treatment over the forecast period.
Global Bronchitis Treatment Market Region-wise Analysis
In 2017, Europe and North America held a lion's share of global bronchitis treatment market and the trend will follow into the forecast period owing to a rapidly ageing population and high prevalence of bronchitis
The global bronchitis treatment market will witness Asia Pacific (APAC) region charting an impressive CAGR of 4.0% owing to increase in government expenditure towards improving healthcare sector and medical outcomes, high prevalence of disorder due to high levels of pollution, and growth in research and development
Analyze bronchitis treatment market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sample of the study,
Competition Landscape
AstraZeneca, Novartis AG, GlaxoSmithKline plc, Dr. Reddy's Laboratories Ltd., Melinta Therapeutics, Sanofi Aventis, and Boehringer Ingelheim International GmbH among others are the key players operating in the global bronchitis treatment market landscape. These are the names that have carved out a large market share for themselves and continue to hold prominence owing to pro-activeness in the market landscape. As per Transparency Market Research, which has profiled these notable players in its market study on bronchitis treatment, players would focus on research and development over the forecast period in order to stay ahead of the curve.
Other strategy that is on the charts for players to be ahead of the competition, and improve market penetration include alliances such as collaborations and mergers. Synergistic partnerships often lead to impressive growth curves in the future.
✔️ Bronchitis Treatment Market to Reach USUSD 4.7 Bn by 2026, High Prevalence of Air Pollution Drives Growth: Transparency Market Research
💕 Found this article helpful? Spread the word and support us!